International legal practice Osborne Clarke has advised Novo Nordisk on a major commercial lease agreement for Carré-Michelet Tower, a restructured/refurbished, high-quality and HQE/BREEAM labelized, office tower in Paris La Defense business district.
Under the agreement, NovoNordisk, a global healthcare company with more than 95 years of innovation and leadership in diabetes care, will occupy approx. 3,300 sq.m in the Tower.
Carré-Michelet Tower is a 9 storey, 34,000 sq.m development by Gecina. Located in the southeast part of the business district of La Défense, the Tower has undergone a major restructuring carried out by Eiffage.
This rehabilitation has enabled:
- 35% increase in the surface area by raising the building with the construction of 7 upper levels on the circular boulevard and 3 other sides of the courtyard, thus adding an additional 10,000 sq.m to the total floor area;
- the separation of two adjoining volumes, highlighting its square shape;
- the renovation of the 7 existing floors;
- the expansion of work spaces with approx. 2,700 sq.m trays.
The architecture of the building has been completely redesigned by the agency Crochon Brullmann & Associés, associated with the agency Architecture et Environnement. A 2,300 m² glass facade, signed by Goyer, a subsidiary of Eiffage specializing in the design and implementation of aluminum and glass facades, replaced the original sloping glass to homogenize the silhouette of the building.
Partner Stéphane Catays and Associates Franck-Olivier Klein and Deborah Boussemart from the Real Estate Team advised on the transaction.
Osborne Clarke is a recognised industry leader in real estate providing a comprehensive sector-led service that provide responsive advice to a variety of major real estate industry organisations, ranging from developers and investors to property funds and corporate occupiers.